CDC Logo Tuberculosis Information CD-ROM   Image of people
jump over main navigation bar to content area
TB Guidelines
Surveillance Reports
Slide Sets
TB-Related MMWRs and Reports
Education/Training Materials
Ordering Information


U.S. Department of Health and Human Services


TB Notes Newsletter

No. 2, 2005

Dear Colleague:

CDC’s annual EIS Conference was held April 11-15 here in Atlanta. Our division was well represented in sessions on tuberculosis investigations by our EIS officers Jawad Asghar, Kevin Cain, Alyssa Finlay, Sarita Shah, and John Oeltmann, as well as by Peter Vranken, an EIS officer assigned to the Louisiana Infectious Disease Epidemiology Section. Congratulations to all of you on a job well done! I also extend my thanks, on behalf of DTBE, to the local TB control and health department staff who played principal roles in the investigations being described. These collaborative investigations are an important component of the training process for EIS officers, and I acknowledge our indebtedness to these state and local public health professionals for their support.

A small group of DTBE staff members gave presentations at the 9th Annual International Union Against Tuberculosis and Lung Disease (IUATLD) North American Region Meeting that was held February 23-26, 2005, in Vancouver, BC, Canada. Another contingent of laboratory scientists from DTBE traveled to Canada April 2-7, 2005, to attend and present posters at the Keystone Symposia on Infectious Disease. The meeting, entitled “Tuberculosis: Integrating Host and Pathogen Biology,” was an important conference for our colleagues in the Mycobacteriology Laboratory Branch.

Members of DTBE were invited to participate in a number of World TB Day events, and also marked the occasion with an in-house luncheon. Please see the articles in this issue about World TB Day activities in Atlanta and other cities.

The Seventh Semi-Annual Tuberculosis Epidemiologic Studies Consortium (TBESC) meeting was held at Corporate Square in Atlanta on May 4 and 5. Participants heard committee and Task Order updates, and split into breakout sessions for further discussions. Currently TBESC members are involved in 17 research projects with study periods ranging from 6 months to 5 years.

The 100th American Thoracic Society (ATS) International Conference took place in San Diego, California, May 20-25. I participated in a town hall meeting convened by Rep. Randy Cunningham and ATS President-elect Peter D. Wagner, MD. This meeting brought together government representatives from the United States and Mexico to discuss joint efforts in improving completion of TB treatment for persons who cross the US-Mexico border. The binational card and information exchange system relying on CureTB and TBNet and other groups were prominently featured. Several symposia and poster sessions provided opportunities to present research and program findings.

On Sunday, May 22, CDC hosted a TB public health poster session that featured 30 posters from across the country. As always, this informal poster session provided an opportunity to learn about new and ongoing activities, as well as an opportunity to see old and new friends and colleagues.

The TB Trials Consortium (TBTC) held its 17th semi-annual meeting prior to the ATS conference. The TBTC meeting was dedicated to Earl S. Hershfield, MD, of Manitoba, Canada, who will retire this year from the TBTC and from TB program work. The meeting was an exceptional one, for many reasons. One outstanding feature was the first presentation of the preliminary results of Study 27, which is evaluating the use of moxifloxacin and the effect of this promising new TB drug on accelerating the time to culture conversion for patients with smear-positive pulmonary TB. Moxifloxacin and other new drug compounds continue to be studied by the TBTC and by other research groups with the objective of making TB therapy easier for all.

The 2005 National TB Controllers Workshop is being held June 28–30 at the J.W. Marriott Lenox Hotel in Atlanta, Georgia. Our planning committee has already sent out the invitation letter, which includes registration and hotel information. We are strongly encouraging use of the secure, online website for both conference and hotel registration; this can be accessed at or Questions should be directed to Ms. Carol Pozsik (678-503-0503) at NTCA or Sherry Brown (404-639-8989) at CDC.

Kenneth G. Castro, MD


Released October 2008
Centers for Disease Control and Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination -

Please send comments/suggestions/requests to:, or to
CDC/Division of Tuberculosis Elimination
Communications, Education, and Behavioral Studies Branch
1600 Clifton Rd., NE - Mailstop E-10, Atlanta, GA 30333